Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

542
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
542
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

6.2K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
6.2K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

868
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
868

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

It's time to test all adults for lipoprotein(a).

Journal of clinical lipidology·2026
Same author

Lipoprotein(a) and Women's Cardiovascular Health: A Review.

JACC. Advances·2026
Same author

Addressing the Lp(a) hypothesis: will lowering Lp(a) decrease the risk of cardiovascular events?

Nature reviews. Cardiology·2026
Same author

Cytosine base editing of LPA in transgenic mice averts large deletions.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Clinical Care for Patients With Elevated Lipoprotein(a) Level in Canada: A Practical Framework for Screening, Risk Assessment, and Management.

The Canadian journal of cardiology·2026
Same author

Lipoprotein(a): An Underappreciated Inherited Risk Factor for Atherosclerosis, Aortic Stenosis, and Abdominal Aortic Aneurysm.

Annual review of medicine·2025

相关实验视频

Updated: Jan 12, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.7K

关于脂蛋白的指导方针的发展 (a)

Michael B Boffa1,2, Marlys L Koschinsky1,3, Robert A Hegele1,2,4

  • 1Robarts Research Institute.

Current opinion in lipidology
|November 5, 2025
PubMed
概括

升高的脂蛋白 (Lp) 是心血管疾病的关键风险因素. 现在的指导方针建议进行普遍的Lp(a) 查,并将水平纳入预防策略,尽管需要更多的研究.

科学领域:

  • 心脏病学 心脏病学
  • 动脉样硬化研究 动脉样硬化研究
  • 脂质学 脂质学是指脂质学.

背景情况:

  • 高血脂蛋白[Lp[a]是动脉样硬化心血管疾病的已知的因果风险因素.
  • 在心血管风险管理中,Lp (a) 已成为一个重要的治疗目标.

研究的目的:

  • 审查过去15年来关于Lp的科学陈述和临床指导方针的演变.
  • 追踪对Lp的建议变化的变化. 管理和查.

主要方法:

  • 在过去15年中发表的全球医疗机构声明和临床指南的系统审查.
  • 对有关Lp (a) 水平和心血管疾病风险的不断变化的建议进行分析.

主要成果:

  • 研究越来越多地表明Lp(a) 与心血管疾病的独立关联,使得风险分层的精细化成为可能.
  • 现在的指导方针主张进行普遍的Lp(a) 查,并将其视为初级预防中增加风险的因素.
  • 尽管越来越多的证据表明,当前建议中的差距和不一致性仍然存在.

结论:

  • 对所有成年人进行常规的Lp (a) 测量和将其纳入心血管疾病预防决策的共识越来越大.
关键词:
动脉样硬化心血管疾病临床指南 临床指南脂蛋白 (a) 是一种蛋白质预防性心脏病学 预防性心脏病学

更多相关视频

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.3K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K

相关实验视频

Last Updated: Jan 12, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.7K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.3K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K
  • 未来的Lp降低疗法的心血管结局试验将塑造临床实践.
  • 建议谨慎行事,因为目前支持共识的证据基础仍然存在空白.